Literature DB >> 32903923

Placing Thermal Ablation for Benign Thyroid Nodules into Context.

Roberto Negro1, Pierpaolo Trimboli2,3.   

Abstract

Year:  2020        PMID： 32903923      PMCID： PMC7445694          DOI： 10.1159/000509310

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN： 2235-0640


× No keyword cloud information.
  17 in total

Review 1.  Diagnosis of endocrine disease: thyroid ultrasound (US) and US-assisted procedures: from the shadows into an array of applications.

Authors:  Enrico Papini; Claudio M Pacella; Laszlo Hegedus
Journal:  Eur J Endocrinol       Date:  2014-03-14       Impact factor: 6.664

2.  Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: A systematic review and meta-analysis.

Authors:  Pierpaolo Trimboli; Marco Castellana; Luca Maria Sconfienza; Camilla Virili; Lorenzo Carlo Pescatori; Roberto Cesareo; Francesco Giorgino; Roberto Negro; Luca Giovanella; Giovanni Mauri
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

3.  Characterization of benign thyroid nodules with HyperSPACE (Hyper Spectral Analysis for Characterization in Echography) before and after percutaneous laser ablation: a pilot study.

Authors:  Simona Granchi; Enrico Vannacci; Elena Biagi
Journal:  Med Ultrason       Date:  2017-04-22       Impact factor: 1.611

4.  Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume.

Authors:  Jung Suk Sim; Jung Hwan Baek; Joongyub Lee; Woojin Cho; Sung Il Jung
Journal:  Int J Hyperthermia       Date:  2017-04-10       Impact factor: 3.914

5.  Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study.

Authors:  Maurilio Deandrea; Francesca Garino; Mormile Alberto; Roberto Garberoglio; Ruth Rossetto; Nadia Bonelli; Stefano Spiezia; Massimo De Santis; Salvatore Monti; Maria Grazia Deiana; Toscano Vincenzo; Christian Cugini; Ghassan El Dalati; Paolo Piero Limone
Journal:  Eur J Endocrinol       Date:  2019-01-01       Impact factor: 6.664

6.  Quality of life and outcomes in patients with a large toxic adenoma undergoing laser ablation plus radioiodine vs lobectomy.

Authors:  Roberto Negro; Gabriele Greco
Journal:  Int J Hyperthermia       Date:  2018-12-16       Impact factor: 3.914

7.  Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group.

Authors:  Stella Bernardi; Fabiola Giudici; Roberto Cesareo; Giovanni Antonelli; Marco Cavallaro; Maurilio Deandrea; Massimo Giusti; Alberto Mormile; Roberto Negro; Andrea Palermo; Enrico Papini; Valerio Pasqualini; Bruno Raggiunti; Duccio Rossi; Luca Maria Sconfienza; Luigi Solbiati; Stefano Spiezia; Doris Tina; Lara Vera; Fulvio Stacul; Giovanni Mauri
Journal:  Thyroid       Date:  2020-07-24       Impact factor: 6.568

8.  Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial).

Authors:  Roberto Cesareo; Claudio Maurizio Pacella; Valerio Pasqualini; Giuseppe Campagna; Mario Iozzino; Andrea Gallo; Angelo Lauria Pantano; Roberto Cianni; Claudio Pedone; Paolo Pozzilli; Chiara Taffon; Anna Crescenzi; Silvia Manfrini; Andrea Palermo
Journal:  Thyroid       Date:  2020-03-17       Impact factor: 6.568

9.  Epidemiological and economic trends in inpatient and outpatient thyroidectomy in the United States, 1996-2006.

Authors:  Gordon H Sun; Sonya DeMonner; Matthew M Davis
Journal:  Thyroid       Date:  2013-05-28       Impact factor: 6.568

10.  What is the care pathway of patients who undergo thyroid surgery in France and its potential pitfalls? A national cohort.

Authors:  Muriel Mathonnet; Anne Cuerq; Christophe Tresallet; Jean-Christophe Thalabard; Elisabeth Fery-Lemonnier; Gilles Russ; Laurence Leenhardt; Claude Bigorgne; Philippe Tuppin; Bertrand Millat; Anne Fagot-Campagna
Journal:  BMJ Open       Date:  2017-04-07       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.